GE HealthCare
↗Chicago, USA (Global); Lindesnes/Oslo, Norway (PDx R&D/Manufacturing)
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. Spun off from General Electric in early 2023, the company operates through four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. It is a dominant player in the global diagnostic imaging market, providing the hardware (MRI, CT, PET) and the essential contrast agents and molecular tracers required for precision diagnosis.
The Pharmaceutical Diagnostics (PDx) segment, where Alf-Martin Farbrot is based, is the world's leading supplier of contrast media. This division manages the entire lifecycle of imaging agents—from API manufacturing in Lindesnes, Norway, to fill-and-finish in Ireland, China, and the US. These agents are used in over 100 million patient procedures annually, facilitating early detection and monitoring of cancer, heart disease, and neurological disorders.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Diagnostics and Medical Imaging
SIZE & FINANCIALS
Employees:10000+
Revenue:$19B-$20B
Founded:1994
Ownership:public
Status:operating
FUNDING
Stage:Public
STOCK
Exchange:NASDAQ
Ticker:GEHC
Market Cap:$38.5B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Omnipaque, Visipaque, DaTSCAN)
Modalities:Small molecule, Contrast agents, Radioisotopes, Diagnostic radiopharmaceuticals
Active Trials:320
Trial Phases:Phase 1: 15 | Phase 2: 25 | Phase 3: 10 | Phase 4: 270
FDA Approvals:85
EMA Approvals:40
CORPORATE STRUCTURE
Subsidiaries:GE Healthcare AS (Norway), BK Medical, Intelerad Medical Systems, MIM Software
Key Partnerships:Mayo Clinic (Radiation therapy & AI), Mass General Brigham (MRI foundation models), Novo Nordisk (Peripheral nerve ultrasound)
COMPETITION
Position:Leader
Competitors:Siemens Healthineers, Philips Healthcare, Medtronic, Stryker, Guerbet (Contrast Media rival), Bracco (Contrast Media rival)
LEADERSHIP
Key Executives:
Peter J. Arduini - President & CEO
Kevin O'Neill - President & CEO, Pharmaceutical Diagnostics
Board Members:Catherine Lesjak, Howard J. Isermann, Anne T. Madden
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GE HealthCare. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.